Profile data is unavailable for this security.
About the company
Hua Medicine is a China-based company principally engaged in the drug development business. The Company is mainly engaged in the development of an oral drug, Dorzagliatin, or HMS5552, for the treatment of Type 2 diabetes. The Company mainly operates its business in the domestic and overseas markets.
- Revenue in HKD (TTM)82.50m
- Net income in HKD-227.48m
- Incorporated2009
- Employees177.00
- LocationHua MedicineHua Medicine, 275 Ai Di Sheng RoadSHANGHAI 201203ChinaCHN
- Phone+86 2 158869997
- Websitehttps://www.huamedicine.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
VIVA Biotech Holdings | 2.32bn | -125.05m | 1.21bn | 2.08k | -- | 0.302 | 10.09 | 0.5214 | -0.0636 | -0.0636 | 1.20 | 1.85 | 0.2805 | 4.84 | 5.21 | 1,117,671.00 | -1.30 | -1.39 | -1.79 | -1.68 | 34.26 | 34.81 | -4.63 | -5.44 | 1.15 | 1.00 | 0.3412 | -- | -9.42 | 59.31 | 78.03 | -- | 31.98 | -- |
Jacobson Pharma Corporation Ltd | 1.68bn | 212.16m | 1.24bn | 1.59k | 5.57 | 0.5198 | 3.13 | 0.7368 | 0.1112 | 0.1409 | 0.8822 | 1.19 | 0.3722 | 2.87 | 7.50 | 940,829.50 | 5.16 | 4.91 | 6.61 | 6.60 | 42.05 | 41.81 | 13.85 | 14.32 | 1.01 | 5.62 | 0.3646 | 35.97 | 11.91 | 2.89 | 41.30 | 4.42 | -6.22 | 6.39 |
CStone Pharmaceuticals | 499.52m | -395.48m | 1.39bn | 230.00 | -- | 2.82 | -- | 2.78 | -0.3135 | -0.3135 | 0.3955 | 0.3831 | 0.2811 | 2.44 | 3.72 | 2,171,846.00 | -22.25 | -54.76 | -48.85 | -81.68 | 65.60 | -- | -79.17 | -301.62 | 1.44 | -- | 0.4431 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
Jacobio Pharmaceuticals Group Co Ltd | 68.41m | -386.75m | 1.40bn | 301.00 | -- | 1.21 | -- | 20.49 | -0.5003 | -0.5003 | 0.0885 | 1.46 | 0.0419 | -- | 5.21 | 227,264.10 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
Essex Bio-Technology Ltd | 1.71bn | 275.26m | 1.41bn | 1.48k | 5.29 | 0.7317 | 4.20 | 0.8248 | 0.4689 | 0.4689 | 2.87 | 3.39 | 0.6161 | 2.28 | 3.35 | 1,152,300.00 | 9.94 | 11.20 | 13.21 | 14.73 | 90.20 | 86.01 | 16.13 | 19.77 | 1.46 | -- | 0.1326 | 16.16 | 29.51 | 7.72 | 22.11 | 3.56 | 7.29 | 7.39 |
Wuhan YZY Biopharma Co Ltd | 0.00 | -206.45m | 1.45bn | 123.00 | -- | 10.55 | -- | -- | -1.11 | -1.11 | 0.00 | 0.7092 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.41 | -100.12 | 0.4138 | -- | -- | -- | -1.50 | -- | -- | -- |
Mabpharm Ltd | 93.87m | -225.46m | 1.51bn | 347.00 | -- | 6.82 | -- | 16.04 | -0.0547 | -0.0547 | 0.0228 | 0.0536 | 0.0893 | 0.1176 | 6.02 | 270,507.70 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
Hua Medicine | 82.50m | -227.48m | 1.67bn | 177.00 | -- | 14.22 | -- | 20.22 | -0.2327 | -0.2327 | 0.0844 | 0.1111 | 0.0538 | 1.69 | 13.03 | 466,121.40 | -14.84 | -25.61 | -17.56 | -28.81 | 48.78 | -- | -275.73 | -1,654.70 | 6.06 | -- | 0.6238 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
Immunotech Biopharm Ltd | 0.00 | -360.58m | 1.70bn | 211.00 | -- | 9.08 | -- | -- | -0.7007 | -0.7007 | 0.00 | 0.3634 | 0.00 | -- | -- | 0.00 | -38.88 | -37.42 | -50.88 | -45.48 | -- | -- | -- | -- | 1.03 | -2.51 | 0.4327 | -- | -- | -- | -5.25 | -- | -8.46 | -- |
Cryofocus Medtech Shanghai Co Ltd | 44.10m | -104.99m | 1.74bn | 392.00 | -- | 9.98 | -- | 39.36 | -0.4391 | -0.4391 | 0.1844 | 0.7272 | -- | -- | -- | 112,500.60 | -- | -- | -- | -- | 75.83 | -- | -258.23 | -- | 4.08 | -- | 0.0597 | -- | 50.83 | -- | 13.13 | -- | -- | -- |
Dawnrays Pharmaceutical (Holdings) Ltd | 1.24bn | 351.08m | 1.77bn | 1.14k | 5.05 | 0.5758 | 3.93 | 1.43 | 0.2336 | 0.2336 | 0.825 | 2.05 | 0.3156 | 2.31 | 6.37 | 1,084,603.00 | 8.85 | 9.89 | 11.36 | 12.49 | 54.60 | 56.69 | 28.03 | 27.89 | 2.26 | 28.89 | 0.0405 | 35.33 | -9.90 | 3.94 | -8.95 | 1.41 | 63.92 | 2.00 |
Cutia Therapeutics | 148.21m | -2.11bn | 1.87bn | 298.00 | -- | 1.28 | -- | 12.60 | -6.96 | -6.96 | 0.4875 | 4.78 | -- | -- | -- | 497,349.40 | -- | -- | -- | -- | 51.60 | -- | -1,426.91 | -- | 5.38 | -- | 0.153 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
SinoMab Bioscience Ltd | 1.47m | -261.81m | 1.88bn | 215.00 | -- | 5.59 | -- | 1,277.42 | -0.2572 | -0.2572 | 0.0014 | 0.3076 | 0.0015 | -- | -- | 6,837.24 | -26.20 | -24.62 | -32.50 | -27.72 | 30.92 | -- | -17,810.33 | -4,451.74 | -- | -11.48 | 0.604 | -- | -- | -- | 14.45 | -- | 106.81 | -- |
TOT Biopharm International Co Ltd | 840.68m | -40.66m | 1.96bn | 551.00 | -- | 2.64 | 372.64 | 2.33 | -0.0561 | -0.0561 | 1.16 | 0.9569 | 0.5808 | 1.87 | 8.03 | 1,525,738.00 | -2.81 | -20.01 | -3.72 | -25.21 | 73.53 | 74.74 | -4.84 | -68.53 | 1.48 | -4.60 | 0.3348 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
Frontage Holdings Corp | 2.03bn | 84.41m | 2.04bn | 1.76k | 24.48 | 0.7603 | 5.63 | 1.00 | 0.0409 | 0.0409 | 0.9806 | 1.32 | 0.463 | 60.63 | 5.32 | 1,153,777.00 | 1.91 | 4.46 | 2.33 | 5.28 | 30.17 | 34.00 | 4.13 | 9.92 | 1.39 | 4.09 | 0.296 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
HighTide Therapeutics Inc | 0.00 | -1.01bn | 2.11bn | 66.00 | -- | 2.56 | -- | -- | -2.14 | -2.14 | 0.00 | 1.60 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0229 | -- | -- | -- | -393.76 | -- | -- | -- |
Data as of Jun 14 2024. Currency figures normalised to Hua Medicine's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
Baillie Gifford & Co.as of 31 May 2024 | 25.00m | 2.37% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 14.26m | 1.35% |
Allspring Global Investments LLCas of 30 Apr 2024 | 9.38m | 0.89% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 5.88m | 0.56% |
CRUX Asset Management Ltd.as of 31 Mar 2023 | 4.07m | 0.39% |
State Board of Administration of Florida Retirement Systemas of 30 Jun 2023 | 2.32m | 0.22% |
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 560.00k | 0.05% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 180.00k | 0.02% |
SSgA Funds Management, Inc.as of 06 Jun 2024 | 156.40k | 0.02% |
Norges Bank Investment Managementas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.